TENX vs TNYA

Tenax Therapeutics, Inc. vs Tenaya Therapeutics, Inc. — Valuation Comparison 2026

TENX

Biotechnology
Tenax Therapeutics, Inc.
Quality
4.5
out of 10
Value Trap
33
LOW
Price
$11.69
Last close
Models
7/13
Active
VS

TNYA

Biotechnology
Tenaya Therapeutics, Inc.
Quality
4.1
out of 10
Value Trap
30
LOW
Price
$0.80
Last close
Models
8/13
Active

Model-by-Model Comparison

ModelType TENX Fair ValueTENX Upside TNYA Fair ValueTNYA Upside
Bayesian DCF Intrinsic $5.58 -52.3% $0.40 -50.0%
First Chicago Scenario $•••.•• ••.•% $•••.•• ••.•%
ML-RIV Intrinsic $•••.•• ••.•% $•••.•• ••.•%
Dynamic NAV Asset-Based $4.63 -60.4% $0.79 -1.2%
PWERM Option-Based $•••.•• ••.•% $•••.•• ••.•%
Regime Cross-Sectional Relative $•••.•• ••.•% $•••.•• ••.•%
Sentiment SOTP Hybrid $•••.•• ••.•% $•••.•• ••.•%
CUCE Ensemble Ensemble $•••.•• ••.•% $•••.•• ••.•%
🔒

Unlock Full 13-Model Comparison

Access all valuation models for TENX vs TNYA — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

TENX vs TNYA — Which Stock Is More Undervalued?

TENX scores higher with a 4.5/10 quality rating vs TNYA's 4.1/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Tenax Therapeutics, Inc. (TENX) and Tenaya Therapeutics, Inc. (TNYA) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

TENX currently trades at $11.69 with a QOC of 4.5/10, while TNYA trades at $0.80 with a QOC of 4.1/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).

TENX
View Full Tenax Therapeutics, Inc. Analysis →
TNYA
View Full Tenaya Therapeutics, Inc. Analysis →